| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$22,674,201 |
|
|
|
Indirect Value
|
$258,390 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$22,932,591 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 11.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-02-02 |
4 |
D |
$956.65 |
$268,819 |
D/D |
(281) |
23,693 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-02-02 |
4 |
OE |
$378.98 |
$151,592 |
D/D |
400 |
23,974 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-31 |
4 |
D |
$953.42 |
$268,864 |
D/D |
(282) |
23,574 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-31 |
4 |
OE |
$378.98 |
$151,592 |
D/D |
400 |
23,856 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-24 |
4 |
D |
$951.26 |
$334,844 |
D/D |
(352) |
23,456 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-24 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
23,808 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-23 |
4 |
D |
$948.50 |
$736,036 |
D/D |
(776) |
23,308 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-23 |
4 |
OE |
$378.98 |
$416,878 |
D/D |
1,100 |
24,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-17 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
23,338 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-17 |
4 |
D |
$932.34 |
$330,048 |
D/D |
(354) |
22,984 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-12 |
4 |
D |
$928.18 |
$527,206 |
D/D |
(568) |
22,838 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-12 |
4 |
OE |
$378.98 |
$303,184 |
D/D |
800 |
23,406 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-04 |
4 |
D |
$917.05 |
$313,631 |
D/D |
(342) |
22,606 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-04 |
4 |
OE |
$378.98 |
$189,490 |
D/D |
500 |
22,948 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-03 |
4 |
OE |
$378.98 |
$416,878 |
D/D |
1,100 |
23,136 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-03 |
4 |
D |
$912.30 |
$627,662 |
D/D |
(688) |
22,448 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-02 |
4 |
D |
$888.34 |
$373,991 |
D/D |
(421) |
22,036 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-02 |
4 |
OE |
$378.98 |
$246,337 |
D/D |
650 |
22,457 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-28 |
4 |
OE |
$378.98 |
$322,133 |
D/D |
850 |
22,419 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-28 |
4 |
D |
$884.88 |
$541,547 |
D/D |
(612) |
21,807 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-27 |
4 |
D |
$872.21 |
$472,738 |
D/D |
(542) |
21,569 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-27 |
4 |
OE |
$378.98 |
$284,235 |
D/D |
750 |
22,111 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-13 |
4 |
D |
$871.12 |
$629,820 |
D/D |
(723) |
21,361 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-13 |
4 |
OE |
$378.98 |
$378,980 |
D/D |
1,000 |
22,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$5,466,667 |
D/D |
(6,381) |
21,084 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
